PROM1 and liver cancer: In this study, we show that the addition of the autophagy inhibitor 3-MA dramatically augmented the capacity of Dox or CD133 aptamer-DOX to eliminate liver cancer stem cells via compromising DOX-induced autophagy activation (Figure 4 and Figure 5, Supplementary Figure S8).